WuXi Biologics collaborates with Sinorda Biomedicine for antibody development

Solvonis expands SVN-015 into depression following positive preclinical data

Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE

Glaukos receives FDA approval for repeat administration of iDose TR

Bio-Techne launches ultra-sensitive neurodegenerative disease assays on Ella platform

MedPal AI announces approval to supply Eli Lilly medicines in UK

Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme

Insilico Medicine agrees drug development collaboration with Qilu Pharmaceutical Group

HanchorBio partners with WuXi Biologics for development and manufacturing of next-gen bi- and multi-functional fusion programmes

United Therapeutics reports positive phase 1 data for bioengineered liver in acute liver failure

Sarepta reports positive three-year EMBARK results for ELEVIDYS in ambulatory Duchenne patients

BioArctic partner Eisai secures FDA priority review for Leqembi Iqlik subcutaneous starting dose

Scancell secures FDA clearance for Phase 3 melanoma trial of iSCIB1+

BioCryst Pharmaceuticals acquires Astria Therapeutics

Insilico Medicine's ISM8969 receives US FDA IND approval for Parkinson's Disease